Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

  • Augustine Rajakumar
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...
  • Ana Sofia Cerdeira
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...
  • Sarosh Rana
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...
  • Zsuzsanna Zsengeller
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...
  • Lia Edmunds
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...
  • Arun Jeyabalan
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...
  • Carl A. Hubel
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...
  • Isaac E. Stillman
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...
  • Samir M. Parikh
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...
  • S. Ananth Karumanchi
    From the Department of Medicine (A.R., A.S.C., S.M.P., S.A.K.), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.A.K.), and Department of Pathology (Z.Z., I.E.S.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Howard Hughes Medical Institute (A.R., S.A.K.), Boston, MA; Gulbenkian Programme for Advanced Medical Education (A.S.C.), Lisbon, Portugal; Magee-Womens Research Institute (L.E., A.J., C.A.H.) and Department of Obstetrics,...

抄録

<jats:p> The cardinal manifestations of the pregnancy-specific disorder preeclampsia, new-onset hypertension, and proteinuria that resolve with placental delivery have been linked to an extracellular protein made by the placenta, soluble fms-like tyrosine kinase 1 (sFlt1), that injures the maternal vasculature. However, the mechanisms by which sFlt1, which is heavily matrix bound, gain access to the systemic circulation remain unclear. Here we report that the preeclamptic placenta's outermost layer, the syncytiotrophoblast, forms abundant “knots” that are enriched with sFlt1 protein. These syncytial knots easily detach from the syncytiotrophoblast, resulting in free, multinucleated aggregates (50–150 μm diameter) that are loaded with sFlt1 protein and mRNA, are metabolically active, and are capable of <jats:italic>de novo</jats:italic> gene transcription and translation. At least 25% of the measurable sFlt1 in the third-trimester maternal plasma is bound to circulating placental microparticles. We conclude that detachment of syncytial knots from the placenta results in free, transcriptionally active syncytial aggregates that represent an autonomous source of sFlt1 delivery into the maternal circulation. The process of syncytial knot formation, shedding of syncytial aggregates, and appearance of placental microparticles in the maternal circulation appears to be greatly accelerated in preeclampsia and may contribute to the maternal vascular injury that characterizes this disorder. </jats:p>

収録刊行物

  • Hypertension

    Hypertension 59 (2), 256-264, 2012-02

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ